APRIL 20–22, 2020

2nd Digital health for Pharma

 The Bellevue Hotel

Philadelphia, PA

Register Today Group

A PREVIEW OF OUR 2020 FACULTY

PAUL-IVANS

Paul Ivans

Founder and CEO

EVOLUTION ROAD

LARRY-BROOKS

Larry Brooks

Principal, Digital Health Practice Leader

EVOLUTION ROAD

AMY-WEST

Amy West

Senior Director, Patient Marketing and Digital Health Innovation

NOVO NORDISK

JAMES-MUSICK

James Musick

Vice President, Head of Neurology Patient Technology U.S.

UCB PHARMACEUTICALS

brennan-spiegel

Brennan Spiegel

Director of Health Services Research

CEDARS SINAI

milena saleh

Milena Saleh

Global Director, Digital Health

SANOFI

rob goodwin

Rob Goodwin

Vice President

PFIZER, INC.

ryan flinn

Ryan Flinn

Innovation Communications Leader

JOHNSON & JOHNSON INNOVATION

nancy phelan

Nancy Phelan

CEO

ADHERE THERAPEUTICS, INC.

shwen gwee

Shwen Gwee

Co-Founder and Global Head of Open Innovation

NOVARTIS

 

bryan mallitz

Bryan Mallitz

Director, Digital Health and Innovation

MERCK VACCINES

rishabh mehreja

Rishabh Mehreja

US Head, Digital Partnerships

NOVARTIS

WHAT TO EXPECT

DH4P is the leading Digital Health conference specifically developed for pharmaceutical and life science commercial organizations.

Co-created by Evolution Road and the Digital Pharma Series teams, this event is designed to help patients, payers, providers, organized systems, ACOs, employers, specialty pharmacies, retail, hospital systems, and digital health companies drive commercial success from opportunities presented through emerging technologies in a rapidly changing global healthcare ecosystem.

Upon inception, DH4P serves to educate life science organizations on how best to leverage digital tools to enhance the commercial model of health and pharma; while also educating patients and bridging the gap between knowledge and information, pre-commercial and commercialization.

You can expect to hear from leading digital health and pharma experts from Merck, Pfizer, Novartis, Sanofi, Roche, Bristol-Myers Squibb, Eli Lilly, and more across the life science value chain.

 

FOR 2020: WE WILL EXPLORE FIVE CORE LEVERAGE MODELS OF LEARNING:

  • INVEST: Analyze equity investments in digital health technology companies
  • INCUBATE/ACCELERATE: Evaluate the current climate for supporting digital health startups via internal incubators and accelerators
  • COMMERCIALIZE: Profile BD&L partnerships that leverage life science commercial capabilities to bring digital health technologies to market
  • COLLABORATE: Develop partnerships that dramatically enhance the value proposition of life science brands to drive commercial impact for those brands by achieving customer goals
  • CO-DEVELOP: Understand how to jointly develop a digital health solution that includes governmental regulatory approval
PREVIEW 2019 ATTENDEES Group
Graphic 1

PAST ATTENDEES

Preview a sample of last year's DH4P attendees
Group
Graphic 2

BECOME A SPONSOR

Connect with industry leaders and build mutually beneficial partnerships
Group
Graphic 3

SIGN UP

Sign up to join Digital Health opinion leaders
Group

WHO ATTENDS

SVPs, VPs, Directors, Heads, and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include: Digital Health (i.e, digital therapeutics, telemedicine, big data/ advanced analytics, connected health and wearables, etc.):

  • Digital Health
  • Digital Innovation
  • Digital Accelerator
  • Digital Marketing
  • Digital Business Development/ Solutions
  • Commercial Excellence/ Operations
  • Commercial Strategy
  • Patient Solutions
  • Patient Engagement
  • Innovation
  • External Innovation
  • BD and In-Licensing
  • Clinical Innovation
  • Clinical Operations
  • HEOR
  • Brand Management
  • Product Management
  • R&D Communications
  • Medical Affairs
  • Legal Counsel and MLR

PRESS

OUR SPONSORS